BR0108957A - Inibidores da atividade da alfa-amilase - Google Patents

Inibidores da atividade da alfa-amilase

Info

Publication number
BR0108957A
BR0108957A BR0108957-9A BR0108957A BR0108957A BR 0108957 A BR0108957 A BR 0108957A BR 0108957 A BR0108957 A BR 0108957A BR 0108957 A BR0108957 A BR 0108957A
Authority
BR
Brazil
Prior art keywords
amylase activity
inhibitor
mol
aqueous solution
active component
Prior art date
Application number
BR0108957-9A
Other languages
English (en)
Other versions
BRPI0108957B1 (pt
Inventor
Takashi Makino
Ritsuo Aiyama
Yoriko Deguchi
Masaaki Watanuki
Masako Nakazawa
Harumi Mizukoshi
Masato Nagaoka
Katsuhisa Harada
Kuniko Osada
Original Assignee
Yakult Honsha Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Kk filed Critical Yakult Honsha Kk
Publication of BR0108957A publication Critical patent/BR0108957A/pt
Publication of BRPI0108957B1 publication Critical patent/BRPI0108957B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/99Enzyme inactivation by chemical treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Zoology (AREA)
  • Medical Informatics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"INIBIDORES DA ATIVIDADE DA <244>-AMILASE". Um inibidor da atividade da <244>-amilase contendo como componente ativo polifenóis que são obtidos pela extração de folhas de goiaba e/ou frutos com um ou mais solventes selecionados entre água e solventes hidrofílicos, eliminando materiais que apresentam um peso molecular menor que 5.000 por ultrafiltração, utilizando cromatografia hidrofóbica com o uso de butila de suporte acondicionada como a fase sólida, eluindo sob gradiente de concentração em etapas de uma solução aquosa 0,02 mol/1 de diidrogeniofosfato monossódico e uma solução aquosa 0,02 mol/1 de fosfato trissódico com taxa de fluxo de 1 ml/min e então coletar uma fração reconhecida como o terceiro pico simples no caso de medição da absorbância a 260 nm; um inibidor da atividade da <244>-amilase contendo como componente ativo polifenóis que apresentam propriedades físico-químicas específicas; e alimentos e bebidas, etc., contendo o mesmo.
BRPI0108957A 2000-03-10 2001-03-09 inibidores da atividade da a-amilase BRPI0108957B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000066896 2000-03-10
PCT/JP2001/001857 WO2001066714A1 (fr) 2000-03-10 2001-03-09 INHIBITEURS DE L'ACTIVITE DE L'AMYLASE-$g(a)

Publications (2)

Publication Number Publication Date
BR0108957A true BR0108957A (pt) 2002-12-24
BRPI0108957B1 BRPI0108957B1 (pt) 2016-05-17

Family

ID=18586179

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0108957A BRPI0108957B1 (pt) 2000-03-10 2001-03-09 inibidores da atividade da a-amilase

Country Status (13)

Country Link
US (1) US7037536B2 (pt)
EP (1) EP1262543B1 (pt)
JP (1) JP5354833B2 (pt)
KR (1) KR20020086503A (pt)
CN (1) CN1264978C (pt)
AR (2) AR027636A1 (pt)
AU (2) AU2001241078B2 (pt)
BR (1) BRPI0108957B1 (pt)
CA (1) CA2402893C (pt)
ES (1) ES2393667T3 (pt)
MX (1) MXPA02008819A (pt)
TW (1) TWI261497B (pt)
WO (1) WO2001066714A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4776149B2 (ja) * 2003-03-28 2011-09-21 クラシエフーズ株式会社 糖質吸収抑制剤および食品
AU2005249147B2 (en) * 2004-06-04 2011-03-24 Poly Gain Pte Ltd Natural sweetener
JP2005350375A (ja) * 2004-06-09 2005-12-22 Kikkoman Corp 血中尿酸値低下剤
JP2006056793A (ja) * 2004-08-18 2006-03-02 Bizen Chemical Co Ltd ポリフェノール含有生成物の製造方法、ポリフェノール含有生成物、α−アミラーゼ阻害剤、抗酸化剤および食用組成物
JP2006056850A (ja) * 2004-08-23 2006-03-02 Suntory Ltd リパーゼ阻害剤
JP2006104181A (ja) * 2004-09-13 2006-04-20 Takahiro Tsujita ブナ科植物由来の糖質分解酵素阻害物質、及びその用途
JP4658560B2 (ja) * 2004-10-06 2011-03-23 備前化成株式会社 更年期障害の改善・治療剤および前立腺ガンおよび乳ガンの予防・治療剤
CN1309826C (zh) * 2004-10-27 2007-04-11 北京北大维信生物科技有限公司 纳豆激酶纯化工艺
EP2450084B1 (en) 2005-06-03 2014-02-19 Horizon Science Pty Ltd Substances having body mass redistribution properties
JP5597345B2 (ja) * 2005-07-12 2014-10-01 株式会社ヤクルト本社 アディポネクチン濃度上昇剤
US20090004270A1 (en) * 2006-01-06 2009-01-01 Amerilab Technologies, Inc. Method of using guava extract
US7611739B2 (en) * 2006-01-06 2009-11-03 Amerilab Technologies, Inc. Method of using guava extract and composition including guava extract
TWI386168B (zh) * 2006-05-18 2013-02-21 Yakult Honsha Kk 番石榴葉萃取物粉末及其製造方法
JP2006298937A (ja) * 2006-07-14 2006-11-02 Kinji Ishida 肥満防止改善組成物およびそれを用いた飲食品
MX2009002413A (es) * 2006-09-19 2009-03-20 Horizon Science Pty Ltd Extractos derivados de la caña de azucar y un proceso para su manufactura.
GB0719542D0 (en) * 2007-10-08 2007-11-14 Barry Callebaut Ag Use of cocoa extract
GB0719544D0 (en) * 2007-10-08 2007-11-14 Barry Callebaut Ag Cocoa extract and use thereof
GB0719545D0 (en) * 2007-10-08 2007-11-14 Barry Callebaut Ag Novel use of cocoa extract
US20080293644A1 (en) * 2007-04-27 2008-11-27 Thomas Eidenberger Guava extract
CN102127508B (zh) * 2010-12-25 2013-01-16 浙江工业大学 α-淀粉酶抑制剂产生菌及其筛选方法
US9572852B2 (en) 2011-02-08 2017-02-21 The Product Makers (Australia) Pty Ltd Sugar extracts
US20150050371A1 (en) 2012-03-09 2015-02-19 Biotropics Malaysia Berhad Extract Formulations of Rhodamnia Cinerea And Uses Thereof
WO2014032100A1 (en) 2012-08-28 2014-03-06 Phytolin Pty Ltd Extraction method
US10350259B2 (en) 2013-08-16 2019-07-16 The Product Makers (Australia) Pty Ltd Sugar cane derived extracts and methods of treatment
CN107213203B (zh) * 2017-06-14 2021-01-05 广东番石榴健康产业有限公司 一种从番石榴叶中提取总多酚的方法
CN107807102A (zh) * 2017-11-02 2018-03-16 威海百合生物技术股份有限公司 一种α‑淀粉酶抑制剂活性的检测方法
CN111504997B (zh) * 2020-05-15 2022-10-18 吉林鑫水科技开发有限公司 玉蜀黍须和秸秆成分提取及各成分体外降糖活性检验方法
CN111568969B (zh) * 2020-06-08 2023-05-09 广西壮族自治区中国科学院广西植物研究所 以多聚体多酚为主的荔枝皮提取物在制备α-淀粉酶抑制剂中的应用
CN113884605B (zh) * 2021-10-14 2023-06-16 安徽科技学院 一种土壤酚类物质用分级式高效分离纯化方法
CN114209057A (zh) * 2021-11-30 2022-03-22 瀚科(浙江)生物科技有限责任公司 一种刺梨天然纳米颗粒及其提取方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5429599B2 (pt) * 1974-12-28 1979-09-25
JPS6036746B2 (ja) 1983-09-06 1985-08-22 備前化成株式会社 グアバ葉エキスからなる健康飲料
JP3018013B2 (ja) * 1989-10-19 2000-03-13 三井農林株式会社 α―アミラーゼ活性阻害剤
JP2670742B2 (ja) * 1993-08-21 1997-10-29 備前化成株式会社 α−アミラーゼ阻害物質
US5554645A (en) * 1994-10-03 1996-09-10 Mars, Incorporated Antineoplastic cocoa extracts and methods for making and using the same
IT1275905B1 (it) * 1995-03-14 1997-10-24 Indena Spa Frazioni polifenoliche di te', loro uso e formulazioni che le contengono
JPH092969A (ja) * 1995-06-20 1997-01-07 O S Kogyo Kk アレルギー疾患治療剤
JP2974946B2 (ja) 1995-09-26 1999-11-10 株式会社ヤクルト本社 グアバ茶飲料
US6294190B1 (en) * 1995-12-26 2001-09-25 Suntory Limited Antiobestic agent containing procyanidin as the active ingredient
JP4109731B2 (ja) * 1997-01-23 2008-07-02 備前化成株式会社 改良グアバ葉エキス抽出法
US5912363A (en) * 1997-08-29 1999-06-15 Interhealth Nutraceuticals Method for extraction of proanthocyanidins from plant material

Also Published As

Publication number Publication date
KR20020086503A (ko) 2002-11-18
US7037536B2 (en) 2006-05-02
ES2393667T3 (es) 2012-12-27
EP1262543A4 (en) 2008-12-31
CA2402893A1 (en) 2002-09-10
CN1264978C (zh) 2006-07-19
AR068851A2 (es) 2009-12-09
JP5354833B2 (ja) 2013-11-27
BRPI0108957B1 (pt) 2016-05-17
MXPA02008819A (es) 2003-02-12
US20030124208A1 (en) 2003-07-03
WO2001066714A1 (fr) 2001-09-13
CA2402893C (en) 2011-01-18
EP1262543A1 (en) 2002-12-04
CN1416464A (zh) 2003-05-07
AU4107801A (en) 2001-09-17
TWI261497B (en) 2006-09-11
EP1262543B1 (en) 2012-10-24
AU2001241078B2 (en) 2006-02-09
AR027636A1 (es) 2003-04-02

Similar Documents

Publication Publication Date Title
BR0108957A (pt) Inibidores da atividade da alfa-amilase
WO2004028487A3 (fr) Composition comprenant un polymere sequence et un agent filmogene
BR0009721A (pt) Inibidores de tirosina quinase de proteìna cìclica
BRPI0415699A (pt) uso de oligossacarìdeo ácido e de oligossacarìdeo neutro, e, composições alimentìcia e lìquida
BR0302672A (pt) Formulação farmacêutica nutriente compreendendo polifenóis e seus usos no tratamento de câncer
ATE377597T1 (de) Anilinochinazoline als protein-tyrosin- kinasehemmer
WO2008034764A3 (de) Kosmetische zubereitungen auf basis molekular geprägter polymere
DK0624595T3 (da) Nor-galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler
WO2009032773A3 (en) Compositions and methods for treating demodex infestations
BRPI0408782A (pt) inibidores cìclicos da proteìna tirosina cinase
WO2005035572A3 (en) Antibody compositions and methods
NO973923D0 (no) Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene
CY1108361T1 (el) ΣΤΑΘΕΡΟ ΣΚΕΥΑΣΜΑ ΠΟΥ ΠΕΡΙΕΧΕΙ TNFR-Fc ΚΑΙ ΑΡΓΙΝΙΝΗ
WO2007048599A3 (de) Drug delivery systeme
BR0112871A (pt) Detecção de analitos para ambientes aquosos
BRPI0922435A2 (pt) &#34;composto de tiazolopiridina moduladores de sirtuina, composição farmacêutica compreendendo o mesmo e seu uso.&#34;
BRPI0503828A (pt) formulações contendo pó, aquosas, lìquidas, não alcoólicas
WO2007009395A8 (en) Schisandrin b preparation
ITMI20042054A1 (it) Apparecchiatura per la preparazione di una bevanda calda
WO2000004865A3 (en) Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
BR9916004A (pt) Inibidores de proteinase c de pró-colágeno
EP1183954A4 (en) DECOLORATION INHIBITORS
BR0016547A (pt) Composição para a modulação e inibição da permeabilidade vascular (vp)
ITMI20031396A1 (it) Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita&#39; antiossidante.
NO20065898L (no) 1-heterocyklyl-1,5-dihydro-pyrido[3,2-b]indol-2-oner

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C12N 9/99 , A23L 1/30 , A61K 35/78 , A61P 43/00 , A61P 3/10 , A61P 3/04

Ipc: C12N 9/99 (2006.01), A61P 43/00 (2006.01), A61P 3/

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/05/2016, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2621 DE 30-03-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.